Edition:
United Kingdom

Humanwell Healthcare Group Co Ltd (600079.SS)

600079.SS on Shanghai Stock Exchange

15.25CNY
18 May 2018
Change (% chg)

¥0.09 (+0.59%)
Prev Close
¥15.16
Open
¥15.14
Day's High
¥15.25
Day's Low
¥15.01
Volume
10,230,658
Avg. Vol
18,012,719
52-wk High
¥21.50
52-wk Low
¥13.52

Chart for

About

Humanwell Healthcare (Group) Co., Ltd is a China-based company principally engaged in research and development, manufacture and distribution of medical and pharmaceutical products. The Company’s products are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines and... (more)

Overall

Beta: 0.79
Market Cap(Mil.): ¥23,290.35
Shares Outstanding(Mil.): 1,286.05
Dividend: 0.11
Yield (%): 0.61

Financials

  600079.SS Industry Sector
P/E (TTM): 32.65 30.95 32.75
EPS (TTM): 0.55 -- --
ROI: 7.48 14.84 14.38
ROE: 7.53 16.34 16.07

BRIEF-Humanwell Healthcare Expects 2017 Net Profit To Rise 108-114 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO RISE 108-114 PERCENT Y/Y VERSUS 832 MILLION YUAN ($131.56 million) YEAR AGO Source text in Chinese: http://bit.ly/2DIIsBj Further company coverage: ($1 = 6.3242 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

29 Jan 2018

BRIEF-Humanwell Healthcare Group sells bio-pharma firm for 350 mln yuan

* Says it sold 100 percent stake in Yichang-based bio-pharma firm for 350 million yuan

26 Dec 2017

BRIEF-Humanwell Healthcare's Unit To Boost Capital Of Lifestyles Healthcare

* SAYS UNIT SIGNS AGREEMENT TO BOOST CAPITAL OF LIFESTYLES HEALTHCARE PTE WITH HEALTH PRODUCTS FIRM'S 59 PERCENT STAKE WORTH $131.1 MILLION Source text in Chinese: http://bit.ly/2kK6weL Further company coverage: (Reporting by Hong Kong newsroom)

19 Dec 2017

BRIEF-Humanwell Healthcare Group completes investment in unit RFSW Investment Pte Ltd

* Says it invested 805.4 million yuan in wholly owned Singapore unit RFSW Investment Pte. Ltd

15 Dec 2017

BRIEF-Humanwell Healthcare Group unit gets approval of clinical trial for Meisuoshuli tablets

* Says its Wuhan-based unit gets approval of clinical trial for Meisuoshuli tablets, which is used for anti-inflammatory, analgesic and antipyretic

06 Dec 2017

BRIEF-Humanwell Healthcare's shareholder bought shares worth 143.7 mln yuan during Jun 28-Nov 29

* SAYS CONTROLLING SHAREHOLDER HAS BOUGHT 143.7 MILLION YUAN ($21.78 million) WORTH OF COMPANY SHARES BETWEEN JUNE 28 AND NOV 29 Source text in Chinese: http://bit.ly/2k9Y2AT Further company coverage: ($1 = 6.5966 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

29 Nov 2017

BRIEF-Humanwell Healthcare Group unit passes FDA approval

* Says its 75 percent-owned unit received approval for its soft capsule named Dutasteride Capsule from U.S Food and Drug Administration

23 Nov 2017

Earnings vs. Estimates